HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effectiveness of an anti-inflammatory drug, loxoprofen, for patients with nocturia.

AbstractAIM:
There is increasing evidence that non-steroidal anti-inflammatory drugs are effective for the treatment of nocturia. In this study, we attempted to investigate the role of loxoprofen sodium (loxoprofen) in the therapeutic management of patients with nocturia.
METHODS:
Fifteen benign protastatic hyperplasia and/or overactive bladder patients (13 males and 2 females, 71.1 +/- 1.5 years old) with three or more voids per night were involved. These patients had received standard drug therapy. Although these patients had received standard drug therapy for more than half a year, they had still three or more episodes of nocturia. The patients took a single dose of 60 mg of loxoprofen at night prior to sleep. Before and 1 week after the initiation of this therapy, the effects of this treatment were assessed by frequency volume chart and a questionnaire.
RESULTS:
In the questionnaire, seven patients answered as excellent, six patients demonstrated improvement of their symptoms, two patients did not show a significant change in their symptoms and no patients demonstrated a deterioration in the symptoms. In frequency volume chart, total void per day, total void per night, total urine volume per day, total night urine volume per day and single voided volume in the night before and after this treatment were 9.97 +/- 0.81 and 8.99 +/- 0.74 per day, 3.82 +/- 0.25 and 1.82 +/- 0.27 per night, 1349 +/- 81 and 1258 +/- 91 mL per day, 567 +/- 46 and 325 +/- 51 mL per night, and 143 +/- 13 and 149 +/- 10 mL, respectively.
CONCLUSION:
Loxoprofen can be effective and useful for patients with nocturia. Our data suggest that the main mechanism of this effect is to decrease urine production during a night's sleep.
AuthorsMotoaki Saito, Masahito Kawatani, Yukako Kinoshita, Keisuke Satoh, Ikuo Miyagawa
JournalInternational journal of urology : official journal of the Japanese Urological Association (Int J Urol) Vol. 12 Issue 8 Pg. 779-82 (Aug 2005) ISSN: 0919-8172 [Print] Australia
PMID16174058 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Phenylpropionates
  • loxoprofen
Topics
  • Aged
  • Anti-Inflammatory Agents, Non-Steroidal (administration & dosage)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Patient Satisfaction
  • Phenylpropionates (administration & dosage)
  • Prostatic Hyperplasia (complications)
  • Treatment Outcome
  • Urinary Incontinence (drug therapy, etiology)
  • Urination Disorders (drug therapy, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: